13F Filings/Anchorage Capital Group, L.L.C.

Anchorage Capital Group, L.L.C.

Hedge FundCIK0001300714LocationNEW YORK, NY 10012, United States

Long U.S. equity positions disclosed to the SEC on Form 13F-HR.

Latest filingQ2 2026Quarter ended30 Jun 2026Filed14 Aug 2026
Firm profile · Form ADV
SEC adviser registration
CRD
135657 · 801-65582
Portfolio Turnover
0%
Of book traded, QoQ
Positions
3
Long U.S. equities
Top 10 Concentration
100%
Of reported value
QoQ Change
$14.2M
Value change
Assets under management
Form ADV RAUM · client mix · 13F over time
Regulatory AUM
$3.7B
Form ADV, as of Mar 2026
100% discretionary ($3.7B)
By client type
Pooled investment vehicles: $3.6B (95.8%) · 37 clients
Pooled investment vehicles
$3.6B · 96%
State/municipal govt entities: $155M (4.2%) · 1 clients
13F AUM over time
$450M
Q2 ’26 · 13F AUM
84%
42 quarters
Reported Holdings
Q2 2026 · upgrade to Pro for past quarters
★ Position spotlightEQPTEQUIPMENTSHARE COM INC · 77.6% of bookThis highlighted stock and its 1Y chart are public
Loading position history…
SecuritySharesMarket ValueEst. CostLast PxEst. Return% PortfolioΔ SharesAction
EQUIPMENTSHARE COM INC
EQPT· Industrials
17.77MSH$349.4M~$19.66$19.550.6%77.6%Unchanged
SENTINELONE INC
S· Information Technology
4.94MSH$83.8M~$16.97$19.8817.1%18.6%Unchanged
GINKGO BIOWORKS HOLDINGS INC
DNA· Health Care
1.75MSH$17.3M~$9.91$6.9529.9%3.8%Unchanged
EQPTEQUIPMENTSHARE COM INCUnchanged
$349.4M· 77.6%· 17.77M SH· · cost $19.66· last $19.55· 0.6%
Industrials · COM CL A · SOLE
SSENTINELONE INCUnchanged
$83.8M· 18.6%· 4.94M SH· · cost $16.97· last $19.88· 17.1%
Information Technology · CL A · SOLE
DNAGINKGO BIOWORKS HOLDINGS INCUnchanged
$17.3M· 3.8%· 1.75M SH· · cost $9.91· last $6.95· 29.9%
Health Care · CL A NEW · SOLE
Sector Breakdown
Q2 2026
Industrials77.6% · $349.4M
Information Technology18.6% · $83.8M
Health Care3.8% · $17.3M